Results 111 to 120 of about 5,218,351 (211)

Identification of a binding site of the human immunodeficiency virus envelope protein gp120 to neuronal specific tubulin

, 2016
Human immunodeficiency virus-1 (HIV) promotes synaptic simplification and neuronal apoptosis, and causes neurological impairments termed HIV-associated neurological disorders (HAND).
Kont, Yasemin Saygide ğer, DEDONI, SIMONA, Tasciotti, Ennio, Avdoshina, Valeria, Paige, Mikell, Corbo, Claudia, Taraballi, Francesca, Mocchetti, Italo, Üren, Aykut   +8 more
core   +1 more source

Advances in HIV-1 Envelope-Based Vaccine Development. [PDF]

Vaccines (Basel)
Chan KW, Jiang X, Wang AL, Kong XP, Wu X.   +4 more
europepmc   +1 more source

Immunogenicity and structure of a stabilized HIV-1 clade C Env from a pediatric elite neutralizer in complex with an autologous bnAb. [PDF]

Front Immunol
Singh S, Kumar S, Chatterjee A, Malhotra L, Pervez M, Rahman A, Andrabi I, Mondal B, Katpara S, Sharma S, Bhakhri H, Gaur A, Bansal T, Iyer V, Hussain AW, Ahmed S, Kumar R, Ethayathulla AS, Lodha R, Dutta S, Luthra K.   +20 more
europepmc   +1 more source

Glycoform-Dependent Antigenicity in gp120 of HIV-1 Envelope Protein

Trends in Glycoscience and Glycotechnology, 2014
openaire   +2 more sources

Engineering Protein-Based HIV Entry Inhibitors: Advances, Challenges, and Translational Strategies. [PDF]

Biomolecules
Kumariya R, Bewley CA.
europepmc   +1 more source

The Wnt5a-PKCδ-GluA1 axis controls synapse-specific plasticity in HIV-1 gp120-induced pain pathogenesis. [PDF]

Brain
Chen X, Spurgat M, Liu X, Maurelli M, Dibua A, Sha C, Wollmuth LP, Tang SJ.   +7 more
europepmc   +1 more source

HIV-1 Tat and gp120 as key drivers of neurodegeneration in the central nervous system. [PDF]

Front Microbiol
Cecchetto R, Diani E, Lotti V, Palmisano A, Lagni A, Mantoan M, Turrina S, Raniero D, Paolone G, Mazzariol A, Gibellini D.   +10 more
europepmc   +1 more source

Distinct allosteric remodeling of HIV-1 Env dynamics on virions by gp41-directed antibodies reveals two modes of neutralization. [PDF]

Elife
Xu W, Gonepudi NK, Liu J, He Y, Katte R, Wang R, Awuah HB, Han Y, Zhang B, Yu J, Hu B, Ho DD, Acharya P, Kwong PD, Lu M.   +14 more
europepmc   +1 more source

Preferential engagement of the anti-inflammatory ATP/adenosine axis by HIV vaccine candidate with V1-deleted envelope in male rhesus macaques. [PDF]

Cell Rep Med
Silva de Castro I, Rahman MA, Bissa M, Goldfarbmuren KC, Schifanella L, Sarkis S, N'guessan KF, Ma ZM, Gutowska A, Stamos JD, Doster MN, Woode EK, Smith JC, Kozlowski PA, Williams LD, McKinnon KM, Tomaras GD, Shen X, Montefiori DC, Santra S, Paquin-Proulx D, Maldarelli F, Cardozo T, Franchini G.   +23 more
europepmc   +1 more source

Clinical immunogenicity assessment of HIV/AIDS vaccines: current progress and future perspectives. [PDF]

Emerg Microbes Infect
Yu H, Wu X, Li T, Nie J.
europepmc   +1 more source